Economic Times |
India's Cipla Launches Copy Of GSK's Top Asthma Drug In Germany, Sweden
Business Insider MUMBAI (Reuters) – India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will … Cipla launches Serroflo in Germany and Sweden with affordable high quality … |
View full post on asthma – Google News